Myriad Genetics Inc. (MYGN) Dipped -12.14% or -4.01 To Price $29.01 On Tuesday

Myriad Genetics Inc. (MYGN) dipped -12.14% or -4.01 to $29.01. It is close to 2.46 million shares traded, which is 345.59% compare to the average total volume 710749. The market cap of MYGN is $2.03 billion. The year to date change is -5.41%. The 52 week price range is from $17.5 to $41.57. Price of MYGN have changed 2.87% during last week. It have changed -0.60% over last month, 1.35% over last 3 months, 2.10% over last 6 months and 67.87% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MYGN is 34.98. It is 20.58% above current price. The 200-day Moving Averages for MYGN is 30.94. It is 6.65% above current price. The 52-week High is 41.57. It is 43.30% from the current price. The 52-week Low is 17.5. It is -39.68% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MYGN is 17.43 on 2018-02-28. Short % to float is 18.84%. There are some statistics of MYGN. It is has market cap $2.03 billion. The share outstanding is 69.85 million. The average volume is 710749. The revenue is 781.60M. The gross profit is 607.30M. The percent of top 15 Institution holding is 71.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MYGN is 15.82%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MYGN is 10.40%.


Share this post